Compare PYXS & HNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PYXS | HNVR |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.6M | 153.5M |
| IPO Year | 2021 | 2022 |
| Metric | PYXS | HNVR |
|---|---|---|
| Price | $2.36 | $25.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $7.00 | ★ $24.50 |
| AVG Volume (30 Days) | ★ 1.3M | 65.3K |
| Earning Date | 05-13-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 1.72% |
| EPS Growth | ★ 3.03 | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | ★ $13,858,000.00 | N/A |
| Revenue This Year | N/A | $35.49 |
| Revenue Next Year | $7,043.98 | $8.61 |
| P/E Ratio | ★ N/A | $101.36 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.97 | $19.91 |
| 52 Week High | $5.55 | $25.61 |
| Indicator | PYXS | HNVR |
|---|---|---|
| Relative Strength Index (RSI) | 49.75 | 68.60 |
| Support Level | $1.37 | $22.09 |
| Resistance Level | $2.92 | N/A |
| Average True Range (ATR) | 0.37 | 0.74 |
| MACD | -0.06 | 0.22 |
| Stochastic Oscillator | 13.11 | 88.16 |
Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly PYX-201), is an investigational antibody-drug conjugate that targets extradomain-B fibronectin (EDB+FN), a component of the tumor extracellular matrix that is expressed in tumors and minimally present in normal tissues. MICVO consists of a fully human monoclonal antibody linked to a microtubule inhibitor payload, designed to bind within the tumor microenvironment and release its payload to kill cancer cells directly, affect nearby cells through a bystander effect, and induce immunogenic cell death, supporting enhanced anti-tumor activity.
Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.